News

Ajinomoto Bio-Pharma Services: Successful Extension of Nucleic Acid Aptamer Pharmacokinetics in Joint Research by Ajinomoto Co., Inc. and RIBOMIC Inc.
AJICAP® Antibody-Drug Conjugate Manufacturing Technology Contributes to Enhanced Efficacy of Antibody DrugsTOKYO, May 7, 2025 ...
Encompass Health Corp.: Encompass Health reports results for first quarter 2025
Increases full-year guidance BIRMINGHAM, Ala., April 24, 2025 /PRNewswire/ -- Encompass Health Corporation (NYSE: EHC), the largest owner and operator of inpatient ...